Whole-genome and Epigenomic Landscapes of Malignant Gastrointestinal Stromal Tumors Harboring


Journal

Cancer research communications
ISSN: 2767-9764
Titre abrégé: Cancer Res Commun
Pays: United States
ID NLM: 9918281580506676

Informations de publication

Date de publication:
04 2023
Historique:
received: 12 09 2022
revised: 12 12 2022
accepted: 17 03 2023
medline: 30 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

Gastrointestinal stromal tumors (GIST) with We present genomic and epigenomic insights into the malignant progression of GISTs with

Identifiants

pubmed: 37377752
doi: 10.1158/2767-9764.CRC-22-0364
pii: CRC-22-0364
pmc: PMC10124575
doi:

Substances chimiques

DNA, Intergenic 0
KIT protein, human EC 2.7.10.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

684-696

Informations de copyright

© 2023 The Authors; Published by the American Association for Cancer Research.

Références

Cancer Sci. 2006 Oct;97(10):1070-4
pubmed: 16918994
Nat Rev Cancer. 2004 Apr;4(4):296-307
pubmed: 15057289
BMC Genomics. 2022 Feb 15;23(1):134
pubmed: 35168570
Proc Natl Acad Sci U S A. 2019 Nov 5;116(45):22746-22753
pubmed: 31636198
Sci Rep. 2017 Apr 4;7(1):641
pubmed: 28377632
Cell Rep. 2019 Jul 30;28(5):1370-1384.e5
pubmed: 31365877
Clin Cancer Res. 2016 Jul 15;22(14):3477-87
pubmed: 26936919
Nature. 2020 Feb;578(7793):112-121
pubmed: 32025012
Cancer Res. 2000 Apr 1;60(7):1961-7
pubmed: 10766186
Cancer Res. 2006 Aug 15;66(16):8163-71
pubmed: 16912195
Eur J Surg Oncol. 2011 Oct;37(10):890-6
pubmed: 21737227
Cancer Prev Res (Phila). 2016 Jul;9(7):534-46
pubmed: 26883721
Int J Cancer. 2003 Oct 10;106(6):887-95
pubmed: 12918066
Cancer Sci. 2013 Jul;104(7):817-25
pubmed: 23521319
J Pathol. 2008 Oct;216(2):225-35
pubmed: 18729075
Nat Genet. 2014 Jun;46(6):601-6
pubmed: 24793134
Nat Rev Mol Cell Biol. 2010 Mar;11(3):220-8
pubmed: 20177397
Genome Biol. 2016 Jun 06;17(1):122
pubmed: 27268795
J Clin Oncol. 2003 May 1;21(9):1688-97
pubmed: 12721243
Hum Pathol. 2008 Oct;39(10):1411-9
pubmed: 18774375
Clin Cancer Res. 2013 Sep 1;19(17):4879-88
pubmed: 23820108
Ann Oncol. 2022 Sep;33(9):959-967
pubmed: 35688358
Nat Med. 2019 Mar;25(3):517-525
pubmed: 30664780
Oncogene. 2011 Apr 14;30(15):1812-21
pubmed: 21242979
Nat Med. 1995 Jul;1(7):686-92
pubmed: 7585152
Nature. 2020 Feb;578(7793):129-136
pubmed: 32025019
Cell Physiol Biochem. 2019;53(3):480-495
pubmed: 31486323
Bioinformatics. 2016 Apr 15;32(8):1220-2
pubmed: 26647377
Nat Rev Cancer. 2007 Mar;7(3):169-81
pubmed: 17318210
Oncogene. 2005 Apr 18;24(17):2899-908
pubmed: 15838523
Nat Rev Dis Primers. 2021 Mar 18;7(1):22
pubmed: 33737510
Nature. 2020 Feb;578(7793):94-101
pubmed: 32025018
Genes Chromosomes Cancer. 2010 May;49(5):412-24
pubmed: 20095042
Nat Commun. 2017 Mar 08;8:14674
pubmed: 28270683
Biomed Res. 2014;35(6):407-12
pubmed: 25743347
Genome Integr. 2013 Oct 24;4(1):5
pubmed: 24152759
Cell Rep. 2016 Dec 6;17(10):2632-2647
pubmed: 27926867
PLoS One. 2016 Jan 07;11(1):e0146370
pubmed: 26741489
PLoS One. 2014 Apr 10;9(4):e94595
pubmed: 24722238
Neoplasia. 2009 Dec;11(12):1371-82
pubmed: 20019845
Genome Res. 2002 Jun;12(6):996-1006
pubmed: 12045153
Cancer Res. 2006 Sep 15;66(18):9153-61
pubmed: 16982758
Cancer Res. 2004 Jun 1;64(11):3741-7
pubmed: 15172977
Ther Adv Med Oncol. 2021 Sep 30;13:17588359211049779
pubmed: 34616493
Lancet. 2013 Sep 14;382(9896):973-83
pubmed: 23623056
Eur J Surg Oncol. 2020 Jun;46(6):1080-1087
pubmed: 32147424
Cancer Sci. 2020 Feb;111(2):687-699
pubmed: 31863614
Nat Genet. 2001 Dec;29(4):365-71
pubmed: 11726920
Cancer Cell Int. 2019 Nov 12;19:289
pubmed: 31749661
J Clin Oncol. 2005 Sep 1;23(25):6190-8
pubmed: 16135486
Gastroenterology. 2006 May;130(6):1573-81
pubmed: 16697720
Nat Rev Cancer. 2011 Nov 17;11(12):865-78
pubmed: 22089421
Clin Cancer Res. 2014 Dec 1;20(23):6105-16
pubmed: 25294914
Cancer Res. 2015 Jan 1;75(1):40-50
pubmed: 25388284
J Biol Chem. 2015 Jul 3;290(27):16653-64
pubmed: 25971970
Cancer Discov. 2022 Jan;12(1):31-46
pubmed: 35022204
Oncogene. 2001 Jul 19;20(32):4419-23
pubmed: 11466625
Nat Genet. 2017 May;49(5):692-699
pubmed: 28369037
Cancer Res. 2007 Mar 1;67(5):2046-53
pubmed: 17332333
Cancer Sci. 2019 Dec;110(12):3821-3833
pubmed: 31553483
Clin Cancer Res. 2020 Oct 1;26(19):5078-5085
pubmed: 32601076
Clin Sarcoma Res. 2019 Mar 05;9:3
pubmed: 30867899
J Cell Sci. 2019 Dec 2;132(23):
pubmed: 31792043
Clin Cancer Res. 2010 Nov 1;16(21):5114-23
pubmed: 20978145
FEBS Lett. 1999 Oct 29;460(2):251-6
pubmed: 10544245
Neoplasma. 2018;65(4):477-493
pubmed: 29940762

Auteurs

Keiichi Ohshima (K)

Medical Genetics Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.

Takeshi Nagashima (T)

Cancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.
SRL, Inc., Tokyo, Japan.

Keiichi Fujiya (K)

Division of Gastric Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan.

Keiichi Hatakeyama (K)

Cancer Multiomics Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.

Yuko Watanabe (Y)

Medical Genetics Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.

Kimiko Morimoto (K)

Medical Genetics Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.

Fukumi Kamada (F)

Cancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.

Yuji Shimoda (Y)

Cancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.

Sumiko Ohnami (S)

Cancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.

Akane Naruoka (A)

Drug Discovery and Development Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.

Masakuni Serizawa (M)

Drug Discovery and Development Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.

Shumpei Ohnami (S)

Cancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.

Hirotsugu Kenmotsu (H)

Division of Genetic Medicine Promotion, Shizuoka Cancer Center Hospital, Shizuoka, Japan.
Division of Thoracic Oncology, Shizuoka Cancer Center Hospital, Shizuoka, Japan.

Akio Shiomi (A)

Division of Colon and Rectal Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan.

Yasuhiro Tsubosa (Y)

Division of Esophageal Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan.

Etsuro Bando (E)

Division of Gastric Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan.

Teiichi Sugiura (T)

Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan.

Takashi Sugino (T)

Division of Pathology, Shizuoka Cancer Center Hospital, Shizuoka, Japan.

Masanori Terashima (M)

Division of Gastric Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan.

Katsuhiko Uesaka (K)

Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan.

Kenichi Urakami (K)

Cancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.

Yasuto Akiyama (Y)

Immunotherapy Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.

Ken Yamaguchi (K)

Shizuoka Cancer Center Hospital and Research Institute, Shizuoka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH